Compare HLN & SYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLN | SYY |
|---|---|---|
| Founded | 2022 | 1969 |
| Country | United Kingdom | United States |
| Employees | 24524 | N/A |
| Industry | Package Goods/Cosmetics | Food Distributors |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.5B | 39.9B |
| IPO Year | N/A | 2003 |
| Metric | HLN | SYY |
|---|---|---|
| Price | $9.97 | $81.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 13 |
| Target Price | N/A | ★ $87.62 |
| AVG Volume (30 Days) | ★ 8.7M | 3.2M |
| Earning Date | 02-26-2026 | 04-28-2026 |
| Dividend Yield | 1.94% | ★ 2.97% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.51 |
| Revenue | N/A | ★ $81,370,000,000.00 |
| Revenue This Year | $6.55 | $4.83 |
| Revenue Next Year | $4.42 | $4.96 |
| P/E Ratio | $49.05 | ★ $32.28 |
| Revenue Growth | N/A | ★ 3.20 |
| 52 Week Low | $8.65 | $68.19 |
| 52 Week High | $11.28 | $91.85 |
| Indicator | HLN | SYY |
|---|---|---|
| Relative Strength Index (RSI) | 61.40 | 49.94 |
| Support Level | $9.62 | $72.04 |
| Resistance Level | $10.03 | $82.74 |
| Average True Range (ATR) | 0.15 | 1.86 |
| MACD | 0.03 | -0.52 |
| Stochastic Oscillator | 66.48 | 22.40 |
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Sysco is the largest foodservice distributor in the US, with an 18% share of the $377 billion vertical. The firm sells and distributes over 500,000 food and nonfood products to about 730,000 customer locations, primarily serving restaurants, which represented 60% of fiscal 2025 sales. The balance of sales stems from healthcare facilities (8%), education and government customers (8%), travel and leisure clients (7%), and other smaller end markets (17%), like cafeterias. By segment, Sysco earns the bulk of its revenue from its US foodservice operations (70%), followed by its international footprint (18%), SYGMA, which focuses on quick-service logistics (10%), and other (2%). The pending Jetro Restaurant Depot deal stands to add $16 billion in sales upon close, expected in fiscal 2027.